Dear Insurers: It's Time to Cover Weight Loss Drugs Universal coverage can increase medication access and improve population health Jul 27, 2022
'Senolytic' Therapy Shows Promise in Neovascular Eye Disease Clearing out dying cells, approach has implications far beyond ophthalmology Jul 14, 2022
Keto Versus Mediterranean Diet: Which Is Better for Diabetes? Crossover study looked at cardiometabolic outcomes for each popular diet Jul 08, 2022
Bye-Bye, 'Life's Simple 7': AHA Redefines Cardiovascular Health by Adding Sleep New metrics and scoring algorithm for heart health in children and adults Jun 29, 2022
EASL Roundup: Path to 'Cure' in Hep B? Low-Carb, High-Fat Diet for NAFLD With T2D Noteworthy research from the European Association for the Study of the Liver annual meeting Jun 29, 2022
Primary Care Screening Flops in Detecting Diabetic Eye Disease Fundoscopy screening had low sensitivity, accuracy in primary care setting Jun 28, 2022
Mixed Bag for Semaglutide in NASH-Related Compensated Cirrhosis Randomized trial showed improvements in cardiometabolic markers, but not liver fibrosis Jun 27, 2022
Gastric Bypass Edges Out Sleeve Gastrectomy for 10-Year Outcomes Randomized trial compared the two popular bariatric surgeries Jun 22, 2022
Diabetes Threatens Long-Term Survival in Metastatic Breast Cancer 5-year survival rates were not affected, however Jun 13, 2022
Prediabetes May Be an Independent Risk Factor for MI Findings reinforce importance of early screening and intervention, researchers says Jun 12, 2022
ADA 2022: Racial Residential Segregation, DKA During COVID, and More Noteworthy research presented at the American Diabetes Association annual meeting Jun 08, 2022
Concerning Trends in Vision Impairment for Adults With Diabetes? Steady decreases in the prevalence of patients with eye problems may be over Jun 07, 2022
Tirzepatide Reduced Albuminuria in T2D Patients With Heart Risk Subanalysis of SURPASS-4 trial compared the GLP-1/GIP agonist against insulin glargine Jun 06, 2022
Is Diabetes a Risk Factor for Long COVID? Possibly. Mixed results in seven-study scoping review Jun 05, 2022
Dulaglutide Improves HbA1c for Youth With Type 2 Diabetes Safety profile consistent with that reported in adults Jun 05, 2022
Tirzepatide Serves Up Major Weight-Loss Win in Patients With Obesity SURMOUNT-1 trial tested GIP/GLP-1 receptor agonist in people without diabetes Jun 05, 2022
Sugar-Sweetened Beverage Taxes Cut Sales by 15% However, evidence of tax undershifting was apparent Jun 01, 2022
No Cardioprotection Seen With Long-Term Metformin or Lifestyle Intervention Both approaches "highly effective" in T2D, but not for preventing CV disease, expert says May 24, 2022
SGLT2 Inhibitors a Better First Drug in Type 2 Diabetes Than Metformin? Observational study suggests some cardiovascular benefit May 23, 2022
Diabetic Pain Relief Lasts With High Frequency Spinal Cord Stimulation Trial followed patients with Senza System for 18 months May 16, 2022
Patients With Type 2 Diabetes and CKD Face Poor COVID Outcomes Severity of kidney disease ups risk of ICU time, in-hospital mortality, and more May 15, 2022
First GLP-1/GIP Receptor Agonist OK'd for Type 2 Diabetes Injectable tirzepatide lands approval as an adjunct to diet and exercise May 13, 2022
GIP/GLP-1 Receptor Agonist Slashes Body Weight by More Than 20% "Impressive" topline results from trial in adults with overweight, obesity without diabetes May 02, 2022
More Evidence That Fenofibrate Slows Diabetic Eye Disease Significant decline in progression to vision-threatening status, proliferative retinopathy Apr 26, 2022
Insulin Glargine Recall; Obesity & Endometrial Cancer; Red Light for Testosterone? News and commentary from the endocrinology world Apr 20, 2022
How Often Does Prediabetes in Seniors Escalate to Full-Blown Disease? Study finds estimated annual progression rate to diabetes of 5.3% Apr 20, 2022
Who Is Really Driving Up Insulin Costs? More attention needs to focus on pharmaceutical middlemen Apr 18, 2022
In Type 2 Diabetes, Metabolic Control Could Add Years to Life Controlling four biomarkers could add as much as a decade to life expectancy Apr 18, 2022
The Winners and Losers of the Proposed Insulin Cost Cap While it benefits some, the $35 cap is only a stopgap measure Apr 08, 2022
Which Anticonvulsant Mood Stabilizer Upped Diabetes Risk? Observational study looked at 5-year risk differences between four agents Apr 06, 2022
Cannabis-Exposed Babies Face Poorer Metabolic Health By age 5, fat mass and glucose levels show the impact Mar 31, 2022
GLP-1 Receptor Agonists: How Safe Are They for the Gallbladder? Link with gallbladder, biliary diseases could be due to weight loss associated with class of drug Mar 28, 2022
E-Cig Use Tied to Higher Odds of Prediabetes As in regular cigarettes, nicotine may play a role, researcher says Mar 03, 2022
More Positive Imcivree Data; ICER Reviews Tirzepatide; SGLT2 Inhibitors for Syncope? News and commentary from the endocrinology world Feb 20, 2022
Gastric Bypass Most Cost-Effective for Severe Obesity, T2D? Modeling study compares Roux-en-Y, conventional medical therapy, and sleeve gastrectomy Feb 14, 2022
FDA OKs 180-Day Implantable Continuous Glucose Monitor Senseonics' Eversense E3 System approved for adults with diabetes Feb 11, 2022
Novel Tirzepatide Wins as Insulin Glargine Add-On Another trial in the SURPASS clinical program met primary endpoint Feb 08, 2022
100,000 Diabetes Deaths; Light's Effect on Blood Sugar; Wegovy Supply Woes Continue News and commentary from the endocrinology world Feb 06, 2022
Warning Labels on Sugary Drinks: Do They Work? Randomized trial found picture warning labels turned parents off Feb 01, 2022
Obesity More Common in Type 1 Diabetes Than Expected And this is putting the population at a higher risk for chronic kidney disease, researchers say Jan 26, 2022
